Advanced Proteome Therapeutics (STU:0E81) Total Inventories: €0.00 Mil (As of Apr. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Advanced Proteome Therapeutics Total Inventories?

Advanced Proteome Therapeutics STU:0E81 Total Inventories is €0.00 Mil as of Apr. 2023.

Advanced Proteome Therapeutics's total inventories for the quarter that ended in Apr. 2023 was €0.00 Mil. Advanced Proteome Therapeutics's average total inventories from the quarter that ended in Jan. 2023 to the quarter that ended in Apr. 2023 was €0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Advanced Proteome Therapeutics's Net-Net Working Capital per share for the quarter that ended in Apr. 2023 was €-0.00.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Advanced Proteome Therapeutics  (STU:0E81) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Advanced Proteome Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in Apr. 2023 is

Net-Net Working Capital Per Share (Q: Apr. 2023 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.036+0.75 * 0.012+0.5 * 0-0.077
-0-0)/41.127
=-0.00

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Advanced Proteome Therapeutics's Days Inventory for the three months ended in Apr. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Apr. 2023 )/Cost of Goods Sold (Q: Apr. 2023 )*Days in Period
=0/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Advanced Proteome Therapeutics's Inventory Turnover for the quarter that ended in Apr. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Apr. 2023 ) / Average Total Inventories (Q: Apr. 2023 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Advanced Proteome Therapeutics's Inventory to Revenue for the quarter that ended in Apr. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Apr. 2023 ) / Revenue (Q: Apr. 2023 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Advanced Proteome Therapeutics Total Inventories Related Terms

Advanced Proteome Therapeutics Total Inventories Historical Data

* Premium members only.

The historical data trend for Advanced Proteome Therapeutics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Proteome Therapeutics Total Inventories Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced Proteome Therapeutics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of €0.00 Mil mean?
Advanced Proteome Therapeutics (STU:0E81) has a Total Inventories of €0.00 Mil as of Apr. 2023. The total amount of inventory as recorded on a company's balance sheet. View historical data for Advanced Proteome Therapeutics and its competitors.
Is Advanced Proteome Therapeutics' Total Inventories too high?
Advanced Proteome Therapeutics' current Total Inventories is €0.00 Mil.
How does Advanced Proteome Therapeutics' Total Inventories compare to VRTX and REGN?
Advanced Proteome Therapeutics' Total Inventories of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Advanced Proteome Therapeutics and its competitors. Advanced Proteome Therapeutics's current Total Inventories is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Proteome Therapeutics stock overvalued right now?
Advanced Proteome Therapeutics (STU:0E81) has a current Total Inventories of €0.00 Mil. The current Total Inventories is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Advanced Proteome Therapeutics (STU:0E81), the current Total Inventories is €0.00 Mil as of Apr. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced Proteome Therapeutics Business Description

Address 104 8337 Eastlake Drive, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.